首页> Life sciences> A longevity study with enhancer substances (selegiline, BPAP) detected an unknown tumor-manifestation-suppressing regulation in rat brain.

A longevity study with enhancer substances (selegiline, BPAP) detected an unknown tumor-manifestation-suppressing regulation in rat brain.

导出 LinkOut

翻译打印收藏纠错

第一作者： J,Knoll

第一单位： Department of Pharmacology and Pharmacotherapy, Faculty of Medicine in Semmelweis University, Budapest, Hungary. Electronic address: knoll.jozsef@med.semmelweis-univ.hu.

作者： J,Knoll ^[1] ; K,Baghy ^[2] ; S,Eckhardt ^[3] ; P,Ferdinandy ^[4] ; M,Garami ^[5] ; L G,Harsing ^[4] ; P,Hauser ^[5] ; Z,Mervai ^[2] ; T,Pocza ^[5] ; Z,Schaff ^[6] ; D,Schuler ^[5] ; I,Miklya ^[4]

作者单位： Department of Pharmacology and Pharmacotherapy, Faculty of Medicine in Semmelweis University, Budapest, Hungary. Electronic address: knoll.jozsef@med.semmelweis-univ.hu. ^[1] 1st Department of Pathology and Experimental Cancer Research, Faculty of Medicine in Semmelweis University, Budapest, Hungary. ^[2] National Institute of Oncology, Budapest, Hungary. ^[3] Department of Pharmacology and Pharmacotherapy, Faculty of Medicine in Semmelweis University, Budapest, Hungary. ^[4] 2nd Department of Pediatrics, Faculty of Medicine in Semmelweis University, Budapest, Hungary. ^[5] 2nd Department of Pathology, Faculty of Medicine in Semmelweis University, Budapest, Hungary. ^[6]

关键词 (2R)-1-(1-benzofuran-2-yl)-N-propylpentane-2-amine (BPAP)Enhancer substances Enhancer-sensitive tumor-manifestation-suppressing (TMS) regulation Fibromyxosarcoma Selegiline/(?)-deprenyl